A detailed history of Adirondack Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Adirondack Trust CO holds 8,614 shares of ABT stock, worth $881,470. This represents 0.41% of its overall portfolio holdings.

Number of Shares
8,614
Previous 8,713 1.14%
Holding current value
$881,470
Previous $959,000 2.09%
% of portfolio
0.41%
Previous 0.43%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$109.52 - $120.96 $10,842 - $11,975
-99 Reduced 1.14%
8,614 $979,000
Q4 2023

Mar 29, 2024

SELL
$90.19 - $110.4 $24,712 - $30,249
-274 Reduced 3.05%
8,713 $959,000
Q3 2023

Oct 31, 2023

BUY
$95.53 - $114.62 $5,922 - $7,106
62 Added 0.69%
8,987 $870,000
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $5,240 - $5,839
-52 Reduced 0.58%
8,925 $973,000
Q1 2023

Apr 28, 2023

SELL
$96.86 - $114.01 $3,874 - $4,560
-40 Reduced 0.44%
8,977 $909,000
Q4 2022

Jan 13, 2023

SELL
$95.06 - $111.52 $16,065 - $18,846
-169 Reduced 1.84%
9,017 $0
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $88,535 - $102,507
915 Added 11.06%
9,186 $889,000
Q2 2022

Jul 06, 2022

BUY
$102.07 - $123.37 $41,644 - $50,334
408 Added 5.19%
8,271 $899,000
Q1 2022

Apr 05, 2022

BUY
$114.02 - $139.04 $93,382 - $113,873
819 Added 11.63%
7,863 $931,000
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $32,898 - $36,394
282 Added 4.17%
7,044 $908,000
Q1 2021

Apr 16, 2021

SELL
$108.84 - $128.23 $4,897 - $5,770
-45 Reduced 0.66%
6,762 $810,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $19,950 - $21,739
190 Added 2.87%
6,807 $841,000
Q3 2020

Oct 05, 2020

SELL
$91.64 - $111.29 $96,222 - $116,854
-1,050 Reduced 13.7%
6,617 $720,000
Q2 2020

Aug 19, 2020

SELL
$76.57 - $98.0 $4,594 - $5,880
-60 Reduced 0.78%
7,667 $772,000
Q1 2020

Apr 23, 2020

BUY
$62.82 - $91.86 $4,711 - $6,889
75 Added 0.98%
7,727 $610,000
Q4 2019

Feb 11, 2020

SELL
$78.51 - $87.4 $54,564 - $60,743
-695 Reduced 8.33%
7,652 $667,000
Q3 2019

Oct 09, 2019

SELL
$81.84 - $88.74 $11,866 - $12,867
-145 Reduced 1.71%
8,347 $698,000
Q2 2019

Jul 15, 2019

BUY
$72.88 - $85.0 $23,686 - $27,625
325 Added 3.98%
8,492 $714,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $11,588 - $14,010
175 Added 2.19%
8,167 $649,000
Q4 2018

Jan 18, 2019

BUY
$65.56 - $74.27 $5,572 - $6,312
85 Added 1.07%
7,992 $578,000
Q3 2018

Oct 22, 2018

SELL
$60.81 - $73.36 $8,148 - $9,830
-134 Reduced 1.67%
7,907 $580,000
Q2 2018

Jul 26, 2018

SELL
$57.57 - $63.54 $2,590 - $2,859
-45 Reduced 0.56%
8,041 $491,000
Q1 2018

May 03, 2018

BUY
$56.27 - $63.62 $44,565 - $50,387
792 Added 10.86%
8,086 $470,000
Q4 2017

Jan 10, 2018

SELL
$53.68 - $57.47 $6,441 - $6,896
-120 Reduced 1.62%
7,294 $416,000
Q3 2017

Oct 12, 2017

BUY
$48.06 - $53.64 $356,316 - $397,686
7,414
7,414 $396,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Adirondack Trust CO Portfolio

Follow Adirondack Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.